Empiric elimination diets for eosinophilic esophagitis: Barriers, facilitators, and impact on quality of life

Funding

This research was supported by the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) . CEGIR ( U54 AI117804 ) is part of the Rare Disease Clinical Research Network, an initiative of the Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), and is funded through collaboration between National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, NCATS, and in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases/National Institutes of Health. CEGIR is also supported by patient advocacy groups including the American Partnership for Eosinophilic Disorders , Campaign Urging Research for Eosinophilic Diseases , and Eosinophilic Family Coalition . As a member of the Rare Disease Clinical Research Network, CEGIR is also supported by its Data Management and Coordinating Center ( U2CTR002818 ). Funding support for the Data Management and Coordinating Center is provided by the NCATS and the National Institute of Neurological Disorders and Stroke.